Drawing for NOBELPHARMA

USPTO serial 79272876

NOBELPHARMA

Reviewed by CopyMark Law Group

Reg. 6015978Status 706Registered
Filing date
Status date
Registration date
Mar 24, 2020
Examiner
ORTIGA PALMER, RAMONA
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with NOBELPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sandra Epp Ryan

Sandra Epp Ryan HSML P.C.45 S. 7th St., Ste. 2700Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; ] pharmaceutical preparations for treating skin disorders [ ; vaccines; vaccines for treating malaria; pharmaceutical preparations for dysmenorrhea; pharmaceutical preparations for hypozincemia; pharmaceutical preparations for tympanic perforation; pharmaceutical preparations for sleep disorders; pharmaceutical preparations for pulmonary alveolar proteinosis; pharmaceutical preparations for distal myopathy; pharmaceutical preparations for CMV infection; pharmaceutical preparations for lymphatic disorder; pharmaceutical preparations for fibrodysplasia ossificans progressive; pharmaceutical preparations for Pendred syndrome ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 15, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 15, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 15, 202571AGREGISTERED-SEC.71 ACCEPTED—
Jul 15, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 17, 2025ES71TEAS SECTION 71 RECEIVED—
Mar 24, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 7, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 24, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 23, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 23, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 23, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 23, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 22, 2020GPNXNOTIFICATION PROCESSED BY IB—
May 7, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 7, 2020FIMPFINAL DISPOSITION PROCESSED—
Apr 23, 2020GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Mar 24, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2019NPUBNOTICE OF PUBLICATION—
Dec 7, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 3, 2019DOCKASSIGNED TO EXAMINER—
Dec 3, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 28, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance